SurvivorNet on MSN
FDA approves Eli Lilly’s daily GLP-1 weight loss pill under new fast-track program, expanding access and flexibility for patients
The U.S. Food and Drug Administration (FDA) has approved a once-daily GLP-1 pill for weight loss called orforglipron, and ...
Fast Track is an FDA program designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. Its purpose is to help important new ...
Bitget debuts VIP Fast Track, shifting from fixed thresholds to trading-based advancement with futures, spot, and asset ...
NASHVILLE, Tenn., Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today ...
The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...
The Dermatology Division of the U.S. Food and Drug Administration has granted Fast Track designation to sonelokimab in moderate-to-severe palmoplantar pustulosis supported by positive results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results